These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 22617774)
1. HMGB1 was a pivotal synergistic effecor for CpG oligonucleotide to enhance the progression of human lung cancer cells. Wang C; Fei G; Liu Z; Li Q; Xu Z; Ren T Cancer Biol Ther; 2012 Jul; 13(9):727-36. PubMed ID: 22617774 [TBL] [Abstract][Full Text] [Related]
2. High-mobility group box 1 promotes metalloproteinase-9 upregulation through Toll-like receptor 4 after cerebral ischemia. Qiu J; Xu J; Zheng Y; Wei Y; Zhu X; Lo EH; Moskowitz MA; Sims JR Stroke; 2010 Sep; 41(9):2077-82. PubMed ID: 20671243 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of HMGB1 A-box reduced lipopolysaccharide-induced intestinal inflammation via HMGB1/TLR4 signaling in vitro. Wang FC; Pei JX; Zhu J; Zhou NJ; Liu DS; Xiong HF; Liu XQ; Lin DJ; Xie Y World J Gastroenterol; 2015 Jul; 21(25):7764-76. PubMed ID: 26167076 [TBL] [Abstract][Full Text] [Related]
4. A role for HMGB1, HSP60 and Myd88 in growth of murine mammary carcinoma in vitro. Chalmers SA; Eidelman AS; Ewer JC; Ricca JM; Serrano A; Tucker KC; Vail CM; Kurt RA Cell Immunol; 2013 Apr; 282(2):136-45. PubMed ID: 23770722 [TBL] [Abstract][Full Text] [Related]
5. Multi-walled carbon nanotube induces nitrative DNA damage in human lung epithelial cells via HMGB1-RAGE interaction and Toll-like receptor 9 activation. Hiraku Y; Guo F; Ma N; Yamada T; Wang S; Kawanishi S; Murata M Part Fibre Toxicol; 2016 Mar; 13():16. PubMed ID: 27026438 [TBL] [Abstract][Full Text] [Related]
6. High mobility group box 1/toll-like receptor 4/myeloid differentiation factor 88 signaling promotes progression of gastric cancer. Yue Y; Zhou T; Gao Y; Zhang Z; Li L; Liu L; Shi W; Su L; Cheng B Tumour Biol; 2017 Mar; 39(3):1010428317694312. PubMed ID: 28347236 [TBL] [Abstract][Full Text] [Related]
7. High-mobility group box 1 inhibits gastric ulcer healing through Toll-like receptor 4 and receptor for advanced glycation end products. Nadatani Y; Watanabe T; Tanigawa T; Ohkawa F; Takeda S; Higashimori A; Sogawa M; Yamagami H; Shiba M; Watanabe K; Tominaga K; Fujiwara Y; Takeuchi K; Arakawa T PLoS One; 2013; 8(11):e80130. PubMed ID: 24244627 [TBL] [Abstract][Full Text] [Related]
8. HMGB1 mediates HAdV-7 infection-induced pulmonary inflammation in mice. Tang Z; Zang N; Fu Y; Ye Z; Chen S; Mo S; Ren L; Liu E Biochem Biophys Res Commun; 2018 Jun; 501(1):1-8. PubMed ID: 29571731 [TBL] [Abstract][Full Text] [Related]
9. Functional expression of TLR9 is associated to the metastatic potential of human lung cancer cell: functional active role of TLR9 on tumor metastasis. Ren T; Wen ZK; Liu ZM; Liang YJ; Guo ZL; Xu L Cancer Biol Ther; 2007 Nov; 6(11):1704-9. PubMed ID: 17986857 [TBL] [Abstract][Full Text] [Related]
10. High mobility group box protein 1 (HMGB1)-partner molecule complexes enhance cytokine production by signaling through the partner molecule receptor. Hreggvidsdóttir HS; Lundberg AM; Aveberger AC; Klevenvall L; Andersson U; Harris HE Mol Med; 2012 Mar; 18(1):224-30. PubMed ID: 22076468 [TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of ethyl pyruvate administration on human gastric cancer growth via regulation of the HMGB1-RAGE and Akt pathways in vitro and in vivo. Zhang J; Zhu JS; Zhou Z; Chen WX; Chen NW Oncol Rep; 2012 May; 27(5):1511-9. PubMed ID: 22246223 [TBL] [Abstract][Full Text] [Related]
12. TLR9 signaling promotes tumor progression of human lung cancer cell in vivo. Ren T; Xu L; Jiao S; Wang Y; Cai Y; Liang Y; Zhou Y; Zhou H; Wen Z Pathol Oncol Res; 2009 Dec; 15(4):623-30. PubMed ID: 19319670 [TBL] [Abstract][Full Text] [Related]
13. Targeting high mobility group box protein 1 ameliorates testicular inflammation in experimental autoimmune orchitis. Aslani F; Schuppe HC; Guazzone VA; Bhushan S; Wahle E; Lochnit G; Lustig L; Meinhardt A; Fijak M Hum Reprod; 2015 Feb; 30(2):417-31. PubMed ID: 25452436 [TBL] [Abstract][Full Text] [Related]
14. High mobility group box 1 protein interacts with multiple Toll-like receptors. Park JS; Gamboni-Robertson F; He Q; Svetkauskaite D; Kim JY; Strassheim D; Sohn JW; Yamada S; Maruyama I; Banerjee A; Ishizaka A; Abraham E Am J Physiol Cell Physiol; 2006 Mar; 290(3):C917-24. PubMed ID: 16267105 [TBL] [Abstract][Full Text] [Related]
15. The HMGB1/RAGE inflammatory pathway promotes pancreatic tumor growth by regulating mitochondrial bioenergetics. Kang R; Tang D; Schapiro NE; Loux T; Livesey KM; Billiar TR; Wang H; Van Houten B; Lotze MT; Zeh HJ Oncogene; 2014 Jan; 33(5):567-77. PubMed ID: 23318458 [TBL] [Abstract][Full Text] [Related]
16. Ethyl pyruvate inhibits proliferation and induces apoptosis of hepatocellular carcinoma via regulation of the HMGB1-RAGE and AKT pathways. Cheng P; Dai W; Wang F; Lu J; Shen M; Chen K; Li J; Zhang Y; Wang C; Yang J; Zhu R; Zhang H; Zheng Y; Guo CY; Xu L Biochem Biophys Res Commun; 2014 Jan; 443(4):1162-8. PubMed ID: 24361892 [TBL] [Abstract][Full Text] [Related]
17. Blockade of high mobility group box-1 signaling via the receptor for advanced glycation end-products ameliorates inflammatory damage after acute intracerebral hemorrhage. Li D; Lei C; Zhang S; Zhang S; Liu M; Wu B Neurosci Lett; 2015 Nov; 609():109-19. PubMed ID: 26483322 [TBL] [Abstract][Full Text] [Related]
18. Association analysis of high-mobility group box-1 protein 1 (HMGB1)/toll-like receptor (TLR) 4 with nasal interleukins in allergic rhinitis patients. Zhu X; Cong J; Yang B; Sun Y Cytokine; 2020 Feb; 126():154880. PubMed ID: 31739216 [TBL] [Abstract][Full Text] [Related]
19. High Mobility Group Box Protein 1 Boosts Endothelial Albumin Transcytosis through the RAGE/Src/Caveolin-1 Pathway. Shang D; Peng T; Gou S; Li Y; Wu H; Wang C; Yang Z Sci Rep; 2016 Aug; 6():32180. PubMed ID: 27572515 [TBL] [Abstract][Full Text] [Related]
20. Selective up-regulation of CDK2 is critical for TLR9 signaling stimulated proliferation of human lung cancer cell. Xu L; Wang C; Wen Z; Yao X; Liu Z; Li Q; Wu Z; Xu Z; Liang Y; Ren T Immunol Lett; 2010 Jan; 127(2):93-9. PubMed ID: 19854217 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]